These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3329538)

  • 1. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal membrane defence mechanism in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Contrib Nephrol; 1987; 57():69-78. PubMed ID: 3315441
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological defenses in CAPD.
    Lamperi S; Carozzi S
    Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses.
    Holmes C; Lewis S
    Perit Dial Int; 1991; 11(2):112-7. PubMed ID: 1854866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.